The global surrogacy market is anticipated to grow at a CAGR of around 6.8% during the forecast period 2021 to 2028 and to reach around US$ 9.9 Bn by 2028.
Changing lifestyle pattern is affecting the consumer’s health sometime resulting in infertility, major players are focused on developing advanced solutions, along with rising awareness among consumers is resulting in demand for surrogacy these are major factors expected to drive the growth of global market. According to Centers for Disease Control and Prevention every year, millions of American families struggle with infertility for every 100 couples, 12 to 13 report they’ve experienced trouble getting pregnant. About 7.3 million women of childbearing age in the U.S. have used fertility treatments to get pregnant. In addition, infertility impacts approximately in 1 in 7 Americans and in 2018, average fertility patient paid over US$ 22,000 per “cycle,” with over 10,000 IVF patients reporting.
Business development activities by major player with the focus to increase the customer base and enhance the profit ration is another factor expected to augment the growth of target market.
In 2016, Cooper Surgical Inc. a global healthcare company that deals with health care medical instruments, devices and disposables acquired Wallace Pharmaceuticals located in India. This acquisition is expected to help the company to enhance the product portfolio of IVF.
In 2015, Irvine Scientific a global leader in design, manufacture, and distribution of products to the industrial cell culture entered in strategic partnership with Biotech Inc. This partnership is expected to help the company to strengthen its position in US market.
In 2020, IVF Spring Fertility Clinic located in India focused on digital marketing campaign in order to create awareness among consumers related to infertility and availability of treatment options. This is expected to create new business opportunities for them and enhance the customer base.
In 2017, Genea a leading players in fertility that offers treatments, such as IVF in collaboration with Merck opened Fertility Centre of Excellence in Bangkok. This is expected to help the company to enhance the business presence.
High government spending on development of present healthcare infrastructure for R&D activities along with deployment of advanced equipments in hospitals in order to facilitate the treatment are factors expected to support the growth of target market.
However, factors such as high cost of the procedure and stringent government regulation related to commercial surrogacy are expected to hamper the growth of global surrogacy market. In addition, low success rate of IVF treatment is another factor expected to challenge the growth of target market.
Increasing R&D activities by major players advancements in IVF treatment, along with focus on introduction of cost-effective treatment are factors responsible to create new opportunities for players operating in the target market over the forecast market. In addition, increasing partnership between regional and international players is expected to support the revenue traction of target market.
Segment Analysis by Region
The market in North America is expected to account for significant revenue share owing to large number of patients suffering from infertility issues. In addition, presence of large number of players operating in the country, availability of advanced infrastructure for R&D activities, along with focus on introduction of innovative solutions are factors expected to support the growth of target market.
Increasing merger and acquisition activities for enhancing the customer base and increase the revenue share are factors expected to support the growth of regional market.
The global market is high highly competitive due to presence of large number of players and innovative product offerings. In addition, business expansion activities through partnerships and agreements are factors expected to further increase the competition.
Global Surrogacy Market
2017 - 2028
2021 - 2028
Type, Technology, Age Group, End Use and Geography
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis
Surrogacy Market Segment Analysis, 2020
The global market is segmented into type, technology, age group, and end use. The technology segment is bifurcated into intrauterine insemination (IUI), in-vitro fertilization (IVF), and others. Among technology the in-vitro fertilization (IVF) segment is expected to account for major revenue share in the global market due to rapid technological advancements by major players.
The end use segment is further divided into hospitals, fertility clinics, and others. The hospital segment is expected to account for significant revenue share in the target segment due to high government spending on development of infrastructure along with availability of reimbursement policies.
The players profiled in the report are Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions, Cardone & Associates Reproductive Medicine & Infertility, LLC, New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC.
Market By Mode of Type
Market By Technology
Intrauterine insemination (IUI)
In-vitro fertilization (IVF)
Market By Age Group
Below 35 years
38 - 39 years
Over 44 years
Market By End User
Market By Region
• Rest of Europe
• South Korea
• Rest of Asia-Pacific
• Rest of Latin America
Middle East & Africa
• South Africa
• Rest of Middle East & Africa
The global surrogacy market in 2027 is expected to be above US$ 9.5 Bn.
In end use segment the hospital segment is growing at faster pace.
The CAGR of the global surrogacy market from 2020-2027 is above 6.5%.
In the global market the Asia Pacific region is expected to grow faster.
Some of the players considered in the report scope are New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC.
Scanfert AVA Clinic, Bourn Hall Fertility Clinic, Nova IVI Fertility, Ovation Fertility, Bangkok IVF Center, Extraordinary Conceptions, Cardone & Associates Reproductive Medicine & Infertility, LLC, New Hope Fertility Center, IVI-RMA Global, Max Healthcare, and Growing Generations, LLC. and others are the prominent players in the surrogacy market.
The surrogacy market is segmented into North America, Europe, Asia Pacific, Latin America and The Middle East & Africa (LAMEA).